Trifast plc (TRI)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 84.40 |
|---|---|
| 52-week range | 55.35 – 93.57 |
| Return, 1 month / 3 months | +5.5% / +7.1% |
| Return, 1 year / 3 years | +4.6% / +20.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -31.2% |
| Average daily value traded | 10.57M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Trifast plc makes and supplies industrial fasteners and related components, including screws, rivets, nuts, bolts and other small engineered parts. Its customers are manufacturers in sectors such as automotive, electronics, domestic appliances and general industrial equipment, who use these components in assembly and production. The company is based in the United Kingdom and serves customers in markets at home and overseas through its distribution and manufacturing operations.
On this site Trifast plc appears as a stock on the London Exchange (UK), code TRI, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Trifast plc (TRI) trades on the London Exchange in UK. It last closed at GBX 84.40 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,306 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.6% and over the last three months it rose 7.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.6% | ||
| From 52-week high | -7.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.1% | ||
| 6-month return | 23.8% | ||
| 12-month return, skipping the last month | -0.9% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.2% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.57M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 25 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | +5.5% |
| 3 months | +7.1% |
| 6 months | +23.8% |
| 1 year | +4.6% |
| 3 years | +20.6% |
| 5 years | −25.3% |
Signals
| 50-day / 200-day average | 85.10 / 74.31 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0130 |
| 5 Mar 2026 | GBP 0.0060 |
| 11 Sep 2025 | GBP 0.0120 |
| 6 Mar 2025 | GBP 0.0060 |
| 12 Sep 2024 | GBP 0.0120 |
| 14 Mar 2024 | GBP 0.0060 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.